Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals - The CoVVac Study

NCT04858607 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT04858607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04858607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals - The CoVVac Study
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Completed
Start date
April 19, 2021
Completion date
January 20, 2023
Enrollment
373 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, immunosuppression